On March 20, 2024, 2seventy bio, Inc. announced that it has issued a press release announcing the appointment of Eli Casdin and Charles Newton to the Board. The press release also discloses that Engine Capital LP nominated 2 candidates, Robert Frankfurt and David Sgro, for election to the Board at the Company?s 2024 annual meeting of stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 USD | +0.20% | +8.77% | +16.16% |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.16% | 254M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- Engine Capital Nominates Candidates to the Board of 2seventy bio